Envestnet Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.6K | Buy |
|
|||||
|
2025
Q1 | $74.5K | Sell |
|
|||||
|
2024
Q4 | $207K | Sell |
|
|||||
|
2024
Q3 | $276K | Buy |
|
|||||
|
2024
Q2 | $207K | Sell |
|
|||||
|
2024
Q1 | $465K | Buy |
|
|||||
|
2023
Q4 | $198K | Sell |
|
|||||
|
2023
Q3 | $113K | Buy |
|
|||||
|
2023
Q2 | $134K | Sell |
|
|||||
|
2023
Q1 | $139K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $233K | Buy |
|
|||||
|
2021
Q4 | $228K | Buy |
|
|||||
|
2021
Q3 | $292K | Sell |
|
|||||
|
2021
Q2 | $332K | Sell |
|
|||||
|
2021
Q1 | $424K | Buy |
|
|||||
|
2020
Q4 | $621K | Sell |
|
|||||
|
2020
Q3 | $481K | Buy |
|
|||||
|
2020
Q2 | $358K | Buy |
|
|||||
|
2020
Q1 | $336K | Buy |
|